JPRN-UMIN000010226已完成2 期
Phase 2 study of whole brain radiotherapy with hippocampal-avoidance and simultaneous integrated boost to brain metastases using intensity modulated radiotherapy - BM HA-SIB-IMRT P2
Division of Radiation Oncology and division of Neurooncology, National Cancer Center Hospital, Tokyo, Japan0 个研究点目标入组 54 人开始时间: 2013年3月12日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 54
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) The distance of hippocampus to metastatic brain tumor < 1.5cm 2) Unknown primary site 3) Primary tumor histology of small cell lung cancer, lymphoma or other blood tumor 4) Radiologically or clinically suspected carcinomatous meningitis 5) With critical comorbidity 6) Allergy to Gd contrast medium 7) In pregnancy or with expectation of pregnancy
研究者
相似试验
已完成
2 期
Phase II trial of stereotactic body radiotherapy with a hydrogel spacer for prostate cancerProstate cancerJPRN-UMIN000026213The University of Tokyo Hospital42
已完成
2 期
ow-dose Whole Brain Radiation Therapy combined with Stereotactic Radiosurgery for Brain Metastases: Multi-institutional Phase II study (JROSG13-1)Brain metastasesJPRN-UMIN000009055iigata University, Dept of Radiology, Japanese Radiation Oncology Study Group70
尚未招募
2 期
Phase II trial of carbon-ion radiotherapy for head and neck cancer(HIMAT1301)non-squamous cell carcinoma at head and neck regionJPRN-UMIN000012414Ion Beam Therapy Center,SAGA HIMAT Foundation30
已完成
不适用
Phase II trial of stereotactic body radiotherapy for non-spine bone metastases.non-spine bone metastasesJPRN-UMIN000033132Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital35
进行中（未招募）
不适用
Phase II study of definitive radiochemotherapy for locally advanced squamous cell cancer of the vulva: an efficacy study - radiotherapy for vulvar canceradvanced stage squamous cell cancer of the vulvaMedDRA version: 8.1Level: LLTClassification code 10047777Term: Vulvar cancerEUCTR2006-004052-20-NLKoningin Wilhelmina Fonds